M2Gen Board of Directors
M2Gen® is a health informatics solutions company focused on accelerating the discovery and development of personalized medicines. M2Gen partners with the nation’s leading cancer centers through ORIEN to create a large, cancer-focused data warehouse linking clinical and molecular data. Using this information, M2Gen helps biopharmaceutical companies address the greatest challenges in oncology drug development.
William S. Dalton, Ph.D., M.D., Executive Chair
Past Director, Personalized Medicine Institute, Moffitt Cancer Center
Mr. James M. Asher
Senior Vice President, Chief Legal & Development Officer, Hearst Health
Mr. Theodore J. Couch, Sr.
President, Premium Mortgage, Inc.
Gregory Dorn, M.D., MPH
President, Hearst Health
Alan F. List, M.D.
President & CEO, Moffitt Cancer Center
Senator Connie Mack
Founding Partner & Senior Policy Advisor, Liberty Partners Group, LLC
Mr. Richard P. Malloch
President, Hearst Business Media
Mr. Allan S. Martin
Co-Founder & CEO, Lumina Analytics
Raphael E. Pollock, MD, PhD, FACS (Non-voting, OSU Observer Designee)
Director, The Ohio State University Comprehensive Cancer Center
Mr. Robert Rothman
President & CEO, Black Diamond Group
Thomas Sellers, Ph.D., MPH
Center Director, Moffitt Cancer Center
Mr. Steven R. Swartz (Non-voting, OSU Observer Designee)
President & CEO, Hearst Health